Cargando…
Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus
The early detection and endoscopic treatment of patients with the dysplastic stage of Barrett's oesophagus is a key to preventing progression to oesophageal adenocarcinoma. However, endoscopic surveillance protocols are hampered by the invasiveness of repeat endoscopy, sampling bias, and a subj...
Autores principales: | Katz‐Summercorn, Annalise, Anand, Shubha, Ingledew, Sophie, Huang, Yuanxue, Roberts, Thomas, Galeano‐Dalmau, Nuria, O'Donovan, Maria, Liu, Hongxiang, Fitzgerald, Rebecca C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653927/ https://www.ncbi.nlm.nih.gov/pubmed/29085666 http://dx.doi.org/10.1002/cjp2.80 |
Ejemplares similares
-
Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023) -
Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018) -
Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016) -
Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023) -
A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma
por: Nieto, Tom, et al.
Publicado: (2018)